- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 10-02-2026: General Updates
10-02-2026 | 08:42 am
10-02-2026 | 08:42 am
Cipla's US subsidiary, InvaGen, received 2 USFDA Form 483 observations following a manufacturing facility inspection in New York. The company plans to address these comprehensively. Investors should note this development regarding operational compliance.
No comments yet. Be the first to comment!